As geopolitical uncertainties persist, the possibility of a Canadian-made version of one of the most popular drugs in the world is prompting conversations about drug manufacturing capabilities in this country.

This entry was posted on Monday, March 9th, 2026 at 7:11 am and is filed under Finance/ Money. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.